# Roles of mitochondrial complexes in non-alcoholic fatty liver disease

**Authors:** Kai Wang, Li Wang, Jiamin Ning, Dexin Li

PMC · DOI: 10.3389/fmolb.2026.1752024 · Frontiers in Molecular Biosciences · 2026-02-23

## TL;DR

This paper reviews how mitochondrial complexes contribute to non-alcoholic fatty liver disease and identifies key patterns in their activity changes.

## Contribution

The study systematically clarifies inconsistent findings about mitochondrial complex activity in NAFLD.

## Key findings

- NAFLD is often linked to reduced mitochondrial complex activity and increased ROS production.
- Some studies show enhanced complex activity, indicating context-dependent adaptations.
- Mitochondrial respiratory complexes are identified as potential therapeutic targets for NAFLD.

## Abstract

Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as a mitochondrial-driven metabolic disorder, yet the specific contributions of individual mitochondrial respiratory chain complexes remain poorly defined. In particular, inconsistent alterations in complexes I–V have been reported across different NAFLD models, representing a critical knowledge gap. Here, we systematically reviewed in vivo and in vitro studies to evaluate changes in mitochondrial complexes I–V during NAFLD progression. Overall, NAFLD is commonly associated with reduced complex activity, impaired mitochondrial respiration, and increased reactive oxygen species production. Notably, a subset of studies reported enhanced complex activity and respiration, suggesting context-dependent mitochondrial adaptations. This synthesis clarifies divergent findings and highlights mitochondrial respiratory complexes as dynamic and therapeutically relevant targets for future NAFLD intervention strategies.

Illustration of mitochondrial dysfunction in NAFLD. Shows complexes I to V within a mitochondrion, highlighting impaired and enhanced mitochondrial respiration pathways. A mouse and lab dishes represent in vivo and in vitro studies. Depicts impacts on energy metabolism, lipid metabolism, and ROS, illustrating how reduced complex activity and elevated ROS can lead to inconsistent changes in NAFLD.

## Linked entities

- **Diseases:** non-alcoholic fatty liver disease (MONDO:0013209), NAFLD (MONDO:0013209)

## Full-text entities

- **Genes:** Hif1a (hypoxia inducible factor 1, alpha subunit) [NCBI Gene 15251] {aka HIF-1-alpha, HIF1-alpha, HIF1alpha, MOP1, bHLHe78}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Dnajc15 (DnaJ heat shock protein family (Hsp40) member C15) [NCBI Gene 66148] {aka 1110003P16Rik, Dnajd1, MCJ}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, NDUFS2 (NADH:ubiquinone oxidoreductase core subunit S2) [NCBI Gene 4720] {aka CI-49, LHONAR2, MC1DN6}, Slc15a3 (solute carrier family 15, member 3) [NCBI Gene 65221] {aka Ci1, cI-1}, Ret (ret proto-oncogene) [NCBI Gene 19713] {aka PTC, RET51, RET9, c-Ret}, Uqcrc2 (ubiquinol cytochrome c reductase core protein 2) [NCBI Gene 67003] {aka 1500004O06Rik}, Cyp2e1 (cytochrome P450, family 2, subfamily e, polypeptide 1) [NCBI Gene 13106] {aka CYPIIE1, Cyp2e}, Cpt2 (carnitine palmitoyltransferase 2) [NCBI Gene 12896] {aka CPTII}, Cox4i1 (cytochrome c oxidase subunit 4I1) [NCBI Gene 12857] {aka COX, COX IV-1, COXIV, Cox4, Cox4a, IV-1}, Timm22 (translocase of inner mitochondrial membrane 22) [NCBI Gene 56322] {aka Tim22}, CPT2 (carnitine palmitoyltransferase 2) [NCBI Gene 1376] {aka CPT1, CPTASE, IIAE4}, Sirt3 (sirtuin 3) [NCBI Gene 64384] {aka 2310003L23Rik, Sir2l3}, Nrf1 (nuclear respiratory factor 1) [NCBI Gene 18181] {aka D6Ertd415e}, Ppara (peroxisome proliferator activated receptor alpha) [NCBI Gene 19013] {aka 4933429D07Rik, Nr1c1, PPAR-alpha, PPARalpha, Ppar}, NDUFB8 (NADH:ubiquinone oxidoreductase subunit B8) [NCBI Gene 4714] {aka ASHI, CI-ASHI, MC1DN32}, Tfe3 (transcription factor E3) [NCBI Gene 209446] {aka F830016E06Rik, Tcfe3, Tfe-3, bHLHe33, mTFE3}, Pink1 (PTEN induced putative kinase 1) [NCBI Gene 68943] {aka 1190006F07Rik, BRPK, mFLJ00387}, Tfeb (transcription factor EB) [NCBI Gene 21425] {aka Tcfeb, bHLHe35}, NDUFB9 (NADH:ubiquinone oxidoreductase subunit B9) [NCBI Gene 4715] {aka B22, CI-B22, LYRM3, MC1DN24, UQOR22}, CYTB (cytochrome b) [NCBI Gene 17711], Sdha (succinate dehydrogenase complex, subunit A, flavoprotein (Fp)) [NCBI Gene 66945] {aka 1500032O14Rik, 2310034D06Rik, 4921513A11, FP, SDH2, SDHF}, NDUFS1 (NADH:ubiquinone oxidoreductase core subunit S1) [NCBI Gene 4719] {aka CI-75Kd, CI-75k, MC1DN5, PRO1304}, Dapk2 (death-associated protein kinase 2) [NCBI Gene 13143], Galr1 (galanin receptor 1) [NCBI Gene 14427] {aka Galnr1}, Pck1 (phosphoenolpyruvate carboxykinase 1, cytosolic) [NCBI Gene 18534] {aka PEPCK, PEPCK-C, Pck-1}, Aass (aminoadipate-semialdehyde synthase) [NCBI Gene 30956] {aka LKR, LKR/SDH, LOR, LOR/SDH, Lorsdh, SDH}, CPT1A (carnitine palmitoyltransferase 1A) [NCBI Gene 1374] {aka CPT I, CPT1, CPT1-L, CPTI-L, L-CPT1}, Sdhd (succinate dehydrogenase complex, subunit D, integral membrane protein) [NCBI Gene 66925] {aka 3110001M13Rik, AVLL5809, CII-4, PRO19626, QPs3, cybS}, Cyc1 (cytochrome c-1) [NCBI Gene 66445] {aka 2610002H19Rik, Cyct1}, Iars1 (isoleucyl-tRNA synthetase 1) [NCBI Gene 105148] {aka 2510016L12Rik, E430001P04Rik, ILRS, Iars}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Sirt1 (sirtuin 1) [NCBI Gene 93759] {aka SIR2L1, Sir2, Sir2a, Sir2alpha}, Sucnr1 (succinate receptor 1) [NCBI Gene 84112] {aka Gpr91}, NDUFA10 (NADH:ubiquinone oxidoreductase subunit A10) [NCBI Gene 4705] {aka CI-42KD, CI-42k, MC1DN22}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Sdhc (succinate dehydrogenase complex, subunit C, integral membrane protein) [NCBI Gene 66052] {aka 0610010E03Rik}, Ppargc1a (peroxisome proliferative activated receptor, gamma, coactivator 1 alpha) [NCBI Gene 19017] {aka A830037N07Rik, Gm11133, PGC-1, PPARGC-1-alpha, Pgc-1alpha, Pgc1}, Mff (mitochondrial fission factor) [NCBI Gene 75734] {aka 5230400G24Rik}, PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1) [NCBI Gene 5564] {aka AMPK, HAMPKb}, Esrra (estrogen related receptor, alpha) [NCBI Gene 26379] {aka ERRalpha, Err1, Estrra, Nr3b1}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, Sdhb (succinate dehydrogenase complex, subunit B, iron sulfur (Ip)) [NCBI Gene 67680] {aka 0710008N11Rik}
- **Diseases:** Mitochondrial complex III dysfunction (MESH:C565128), Mitochondrial complexes IV and V dysfunction (MESH:D030401), insulin resistance (MESH:D007333), mitochondrial defects (MESH:C565376), hepatocellular carcinoma (MESH:D006528), necrosis (MESH:D009336), lipid (MESH:D011017), WD (MESH:D020241), Mitochondrial complex II dysfunction (MESH:C565375), hepatocellular injury (MESH:D056486), metabolic liver disorder (MESH:D017093), NAFLD (MESH:D065626), diabetes (MESH:D003920), hepatic fibrosis (MESH:D008103), hepatic dysfunction (MESH:D008107), inflammation (MESH:D007249), metabolic syndrome (MESH:D024821), fibrosis (MESH:D005355), Dysfunction of respiratory chain complexes (MESH:D028361), Flashes (MESH:D019584), metabolic diseases (MESH:D008659), Choline- (MESH:D002796), hepatic steatosis (MESH:D005234), respiratory dysfunction (MESH:D012131), obese (MESH:D009765), NASH (MESH:D005235), complex I dysfunction (MESH:C537475)
- **Chemicals:** L-amino acid (MESH:D000596), NADP(H) (MESH:D009249), FAD (MESH:D005182), fatty acid (MESH:D005227), superoxide (MESH:D013481), CoQ (-), Thioacetamide (MESH:D013853), proton (MESH:D011522), sodium (MESH:D012964), NAD+ (MESH:D009243), DHT (MESH:D013196), fumarate (MESH:D005650), glucose (MESH:D005947), ubiquinol (MESH:C003741), ROS (MESH:D017382), ATP (MESH:D000255), AMP (MESH:D000249), Paraformaldehyde (MESH:C003043), Lipid (MESH:D008055), coenzyme Q (MESH:D014451), royal jelly (MESH:C058787), choline (MESH:D002794), ADP (MESH:D000244), polyacrylamide (MESH:C016679), tricarboxylic acid (MESH:D014233), Succinate (MESH:D019802), methionine (MESH:D008715), fat (MESH:D005223), Pi (MESH:D010716), inorganic phosphate (MESH:D010710), sugar (MESH:D000073893), Fenofibrate (MESH:D011345), molecular oxygen (MESH:D010100), cholesterol (MESH:D002784), H2O (MESH:D014867), iron (MESH:D007501), FFA (MESH:D005230)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), HepaRG — Homo sapiens (Human), Hepatitis C infection, Cancer cell line (CVCL_9720), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12968024/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12968024/full.md

## References

164 references — full list in the complete paper: https://tomesphere.com/paper/PMC12968024/full.md

---
Source: https://tomesphere.com/paper/PMC12968024